Geriatric co-management leads to safely performed cytoreductive surgery in older women with advanced stage ovarian cancer treated at a tertiary care cancer center

Abstract

AUTHOR CONTRIBUTIONS Olga T. Filippova: Conception and design; analysis and interpretation of data; drafting of article; revising article critically for important intellectual content; final approval of version to be published; agrees to be accountable for all aspects of the work. Dennis S. Chi: Conception and design; analysis and interpretation of data; drafting of article; final approval of version to be published; agrees to be accountable for all aspects of the work. Kara Long Roche: Interpretation of data; revising article critically; final approval of version to be published; agrees to be accountable for all aspects of the work. Yukio Sonoda: Interpretation of data; revising article critically; final approval of version to be published; agrees to be accountable for all aspects of the work. Oliver Zivanovic: Interpretation of data; revising article critically; final approval of version to be published; agrees to be accountable for all aspects of the work. Ginger J. Gardner: Interpretation of data; revising article critically; final approval of version to be published; agrees to be accountable for all aspects of the work. William P. Tew: Interpretation of data; revising article critically; final approval of version to be published; agrees to be accountable for all aspects of the work. Roisin O'Cearbhaill: Interpretation of data; revising article critically; final approval of version to be published; agrees to be accountable for all aspects of the work. Saman Sarraf: Interpretation of data; revising article critically; final approval of version to be published; agrees to be accountable for all aspects of the work. Sung Wu Sun: Interpretation of data; revising article critically; final approval of version to be published; agrees to be accountable for all aspects of the work. Koshy Alexander: Interpretation of data; revising article critically; final approval of version to be published; agrees to be accountable for all aspects of the work. Beatriz Korc-Grodzicki: Interpretation of data; revising article critically; final approval of version to be published; agrees to be accountable for all aspects of the work. Armin Shahrokni: Conception and design; analysis and interpretation of data; drafting of article; revising article critically for important intellectual content; final approval of version to be published; agrees to be accountable for all aspects of the work.

Association of Geriatric Comanagement and 90-Day Postoperative Mortality Among Patients Aged 75 Years and Older With Cancer

“…[9][10][11] Data on the benefits of geriatric comanagement of care for patients with cancer are limited. A 2019 study 12 found that cytoreductive surgical treatment among older women with advanced ovarian cancer who were frail could be performed safely if perioperative comanagement was used.…”

“…Data on the benefits of geriatric comanagement of care for patients with cancer are limited. A 2019 study found that cytoreductive surgical treatment among older women with advanced ovarian cancer who were frail could be performed safely if perioperative comanagement was used. At present, only a minority of surgeons collaborate in any way with geriatricians in the delivery of perioperative care for older patients with cancer …”

Frailty and long-term survival of patients with ovarian cancer: A systematic review and meta-analysis

“…Moreover, geriatric co-management in cancer patients with frailty is also clinical significance, which may increase their tolerability to anticancer treatments and finally improve the clinical outcomes. For example, a previous study showed that in older women with advanced OC and frailty, preoperative/postoperative geriatric and surgical co-management may improve their tolerance to cytoreductive surgery and subsequent postoperative outcomes ( 49 ). Similarly, a recent clinical study confirmed that a geriatric assessment and intervention could reduce the serious toxic effects from cancer treatment in older patients with advanced cancer ( 50 ).…”

The perceived value of a geriatrics‐surgery co‐management program: Perspectives from three surgical specialties

“…In this model of care, surgical and geriatric teams partner to provide surgical care aligned with geriatric care principles. 11 To date, research on GSCM programs has focused largely on partnership between geriatrics and orthopedic surgery, [12][13][14][15][16][17][18][19][20][21][22][23][24][25][26] and to a much lesser extent between geriatrics and oncologic surgery, [27][28][29] neurosurgery, 30,31 or vascular surgery. 32,33 Most of the studies have focused on clinical impact and suggest that these programs can improve many quality-of-care indicators including time to surgery, length of stay, mortality rates, readmission rates, adverse events, complications, prescription of inappropriate medication, use of critical care services, unplanned intubation, pneumonia, comprehensiveness of medical care, functional status, and satisfaction.…”